首页> 外文期刊>Water Science and Technology >Biological treatment of pharmaceutical wastewater from the antibiotics industry
【24h】

Biological treatment of pharmaceutical wastewater from the antibiotics industry

机译:抗生素行业制药废水的生物处理

获取原文
获取原文并翻译 | 示例
       

摘要

Pharmaceutical wastewater generated by an antibiotics (penicillin) company was treated by aerobic membrane bioreactors (MBRs) and sequencing batch reactors (SBRs). At a low organic loading rate of 0.22 kg-COD m-3 d-1, both types of reactors were capable of treating the wastewater such that the treated effluent met the discharge regulation except for the total dissolved solids. However, when the loading rate was increased to 2.92 kg-COD m-3 d-1, foaming issues resulted in unstable performance. Overall, the MBRs achieved better solid removal but the SBRs performed better in regards to the degradation of aromatic compounds, as determined by UV absorbance (UVA). Finally, ozonation was applied on two different streams and showed promise on the strong stream - that corresponds to the formulation effluent and contains most of the biorefractory compounds. Ozonation successfully reduced the UVA, lowered the pH and increased the biochemical oxygen demand: chemical oxygen demand (BOD5: COD) ratio of the strong stream. However, it was less efficient on the effluent having undergone pre-treatment by a biofilter due to a lack of selectivity towards refractory compounds.
机译:抗生素(青霉素)公司产生的制药废水经过好氧膜生物反应器(MBR)和分批测序反应器(SBR)处理。在0.22 kg-COD m-3 d-1的低有机负荷率下,两种类型的反应器均能够处理废水,使得除总溶解固体外,处理后的废水均满足排放规定。但是,当加载速率增加到2.92 kg-COD m-3 d-1时,发泡问题导致性能不稳定。总体而言,MBRs的固相去除效果更好,但SBRs的芳族化合物降解效果更好,这是通过UV吸收率(UVA)确定的。最后,在两种不同的物流上进行了臭氧氧化,并在强物流上显示出了希望-这对应于配方废水,并包含大多数生物难降解化合物。臭氧化成功地降低了强流的UVA,降低了pH值并增加了生化需氧量:化学需氧量(BOD5:COD)的比率。然而,由于缺乏对难熔化合物的选择性,因此在经过生物滤池预处理的废水中效率较低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号